Abstract
In this review we demonstrate how the interplay of genomics, bioinformatics and genomic technologies has enabled an in-depth analysis of the component enzymes of the bacterial fatty-acid biosynthesis pathway as a source of novel antibacterial targets. This evaluation has revealed that many of the enzymes are potentially selective, broad-spectrum antibacterial targets. We also illustrate the suitability of some of these targets for HTS. Furthermore, we discuss how the availability of a robust selectivity assay, mode-of-action assays and numerous crystal structures provide an excellent set of tools with which to initiate integrated programs of research to identify novel antibiotics targeted at these enzymes.
Original language | English (US) |
---|---|
Pages (from-to) | 537-544 |
Number of pages | 8 |
Journal | Drug Discovery Today |
Volume | 6 |
Issue number | 10 |
DOIs | |
State | Published - May 15 2001 |
Externally published | Yes |